GLEIBERMAN ANATOLI,BURDELYA LYUDMILA,GUDKOV ANDREI
申请号：
NZ61261512
公开号：
NZ612615A
申请日:
2012.01.10
申请国别(地区):
NZ
年份:
2015
代理人:
摘要：
Disclosed is the use of a Toll-Like Receptor (TLR) agonist for the manufacture of a medicament for the treatment of cancer in a mammal, wherein the cancer is present in a tissue that expresses TLR5, the TLR agonist comprising the amino acid sequence of SEQ ID NO: 8, wherein the sequence is as defined in the specification.
